38
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

An Exploratory Study of Physician Decision-Making When Treating Uncontrolled COPD

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1357-1373 | Received 14 Dec 2023, Accepted 14 May 2024, Published online: 18 Jun 2024

References

  • National Heart Lung and Blood Institute. What is COPD? 2022. Available from: https://www.nhlbi.nih.gov/health/copd. Accessed April 17, 2023.
  • Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317–1325. doi:10.1164/rccm.202204-0671PP
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2023 report; 2023. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed April 17, 2023.
  • Lipari M, Kale-Pradhan PB, Wilhelm SM. Dual- versus mono-bronchodilator therapy in moderate to severe COPD: a meta-analysis. Ann Pharmacother. 2020;54(12):1232–1242. doi:10.1177/1060028020932134
  • Koarai A, Yamada M, Ichikawa T, Fujino N, Kawayama T, Sugiura H. Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis. Respir Res. 2021;22(1):183. doi:10.1186/s12931-021-01777-x
  • Sehl J, O’Doherty J, O’Connor R, O’Sullivan B, O’Regan A. Adherence to COPD management guidelines in general practice? A review of the literature. Ir J Med Sci. 2018;187(2):403–407. doi:10.1007/s11845-017-1651-7
  • Blanchette CM, Gross NJ, Altman P. Rising costs of COPD and the potential for maintenance therapy to slow the trend. Am Health Drug Benefits. 2014;7(2):98–106.
  • Carlin BW, Schuldheisz SK, Noth I, Criner GJ. Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgrad Med. 2017;129(7):725–733. doi:10.1080/00325481.2017.1353885
  • Perez X, Wisnivesky JP, Lurslurchachai L, Kleinman LC, Kronish IM. Barriers to adherence to COPD guidelines among primary care providers. Respir Med. 2012;106(3):374–381. doi:10.1016/j.rmed.2011.09.010
  • KFF. Key facts about the uninsured population; 2022. Available from: https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/#:~:text=The%20number%20of%20uninsured%20individuals,to%2027.5%20million%20in%202021. Accessed May 23, 2023.
  • Peabody JW, Luck J, Glassman P, et al. Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med. 2004;141(10):771–780. doi:10.7326/0003-4819-141-10-200411160-00008
  • Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression models in biostatistics: linear, logistic, survival, and repeated measures models. 2nd ed. New York, NY: Springer Science & Business Media; 2012.
  • Foster JA, Yawn BP, Maziar A, Jenkins T, Rennard SI, Casebeer L. Enhancing COPD management in primary care settings. MedGenMed. 2007;9(3):24.
  • Gold PM. The 2007 GOLD guidelines: a comprehensive care framework. Respir Care. 2009;54(8):1040–1049.
  • Gäbler M, Ohrenberger G, Funk GC. Treatment decisions in end-stage COPD: who decides how? A cross-sectional survey of different medical specialties. ERJ Open Res. 2019;5(3):00163–02018. doi:10.1183/23120541.00163-2018
  • Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to COPD treatment: myth and reality. Respir Med. 2017;129:117–123. doi:10.1016/j.rmed.2017.06.007
  • Meiwald A, Gara-Adams R, Rowlandson A, et al. Qualitative validation of COPD evidenced care pathways in Japan, Canada, England, and Germany: common barriers to optimal COPD care. Int J Chron Obstruct Pulmon Dis. 2022;17:1507–1521. doi:10.2147/COPD.S360983
  • Mannino D, Siddall J, Small M, Haq A, Stiegler M, Bogart M. Treatment patterns for chronic obstructive pulmonary disease (COPD) in the United States: results from an observational cross-sectional physician and patient survey. Int J Chron Obstruct Pulmon Dis. 2022;17:749–761. doi:10.2147/COPD.S340794
  • Mathioudakis AG, Ananth S, Vestbo J. Stigma: an unmet public health priority in COPD. Lancet Respir Med. 2021;9(9):955–956. doi:10.1016/S2213-2600(21)00316-7
  • Woo S, Zhou W, Larson JL. Stigma experiences in people with chronic obstructive pulmonary disease: an integrative review. Int J Chron Obstruct Pulmon Dis. 2021;16:1647–1659. doi:10.2147/COPD.S306874
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2021 report; 2021. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed September 14, 2023.
  • Overington JD, Huang YC, Abramson MJ, et al. Implementing clinical guidelines for chronic obstructive pulmonary disease: barriers and solutions. J Thorac Dis. 2014;6(11):1586–1596. doi:10.3978/j.issn.2072-1439.2014.11.25
  • López-Campos JL, Abad Arranz M, Calero-Acuña C, et al. Guideline adherence in outpatient clinics for chronic obstructive pulmonary disease: results from a clinical audit. PLoS One. 2016;11(3):e0151896. doi:10.1371/journal.pone.0151896
  • Kimmelman J, Mogil JS, Dirnagl U. Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol. 2014;12(5):e1001863. doi:10.1371/journal.pbio.1001863
  • Gaeckle N, Davis T, Parab P, et al. Higher electronic COPD Assessment Test (eCAT) scores are associated with an increased number of acute exacerbations observed among individuals with COPD receiving care at M Health Fairview (MHF). Am J Respir Crit Care Med. 2023;207:A3094. doi:10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A3094